Source: ERS Skills Course 2016
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
O. Bintcliffe (Bristol, United Kingdom). IPCs in non-malignant disease. ERS Skills Course 2016

Member's Comments

No comment yet.

Related content which might interest you: Effectiveness of mesenchimal stem cells in the treatment  of patients with chronical obstructive pulmonary disease Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Subsequent COPD and lung cancer in patients with autoimmune disease Source: Eur Respir J 2011; 37: 463 Year: 2011 Neuroendocrine cells in lung development and disease Source: Eur Respir Monogr 2021; 91: 44-55 Year: 2021 Characterization of in vitro differentiated bronchial epithelial cells obtained from patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 99s Year: 2004 Pancreatic polypeptide is increased in patients with advanced malignant disease including lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 232s Year: 2002 Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Increased expression of TERT mRNA expresssion in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): Preliminary results Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 OSA with intertitial lung diseases Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016 Upregulation of myeloid derived suppressor cells (MDSCs) in chronic obstructive pulmonary disease and its relationship with disease severity Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Endothelial progenitor cells in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment Year: 2008 Mast cells in lung disease Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Intersections of lung progenitor cells, lung disease and lung cancer Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017 Year: 2017 Circulating tumor cells in chronic obstructive pulmonary disease patients Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 Bilateral lung cancer with COPD or metastatic disease Source: International Congress 2016 – CC4 Major challenges in thoracic surgical oncology Year: 2016 Senotherapies for chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020 Phenotypically aberrant and clonal T cell in the lung of patients with refractory coeliac disease Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Mucine secretion by airways epithelial cells in chronic obstructive lung disease Source: Annual Congress 2004 - Epithelial - microenvironmental interactions in neoplastic and non-neoplastic lung diseases Year: 2004 Accompanying diseases in lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 127s Year: 2006